Prestroke antiplatelet agents in first-ever ischemic stroke: Clinical effects

Conclusions: PA use was associated with decreased first-ever stroke severity, suggesting that it has a beneficial effect. Classification of evidence: This study provides Class II evidence that prestroke use of antiplatelet agents reduces stroke severity in patients with first-ever acute ischemic stroke.

http://www.neurology.org/cgi/content/short/84/11/1080?rss=1

Source: Neurology - March 16, 2015 Category: Neurology Authors: Jung, J.-M., Choi, J., Eun, M.-Y., Seo, W.-K., Cho, K.-H., Yu, S., Oh, K., Hong, S., Park, K.-Y. Tags: MRI, All Cerebrovascular disease/Stroke, Class II, Case control studies, Natural history studies (prognosis) ARTICLE Source Type: research